ESF Stock Overview
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Eurofins Scientific SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €505.00 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | 0.58 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | 900.79% |
| 5 Year Change | 851.04% |
| Change since IPO | 2,177.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| ESF | CH Life Sciences | CH Market | |
|---|---|---|---|
| 7D | 0% | -3.7% | -1.3% |
| 1Y | 0% | -7.7% | -2.8% |
Return vs Industry: ESF exceeded the Swiss Life Sciences industry which returned -25.4% over the past year.
Return vs Market: ESF exceeded the Swiss Market which returned -1.2% over the past year.
Price Volatility
| ESF volatility | |
|---|---|
| ESF Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 5.5% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.7% |
| 10% least volatile stocks in CH Market | 1.9% |
Stable Share Price: ESF has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ESF's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 61,379 | Gilles Martin | www.eurofins.com |
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 130,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics.
Eurofins Scientific SE Fundamentals Summary
| ESF fundamental statistics | |
|---|---|
| Market cap | CHF11.34b |
| Earnings (TTM) | CHF564.71m |
| Revenue (TTM) | CHF6.53b |
20.1x
P/E Ratio1.7x
P/S RatioIs ESF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ESF income statement (TTM) | |
|---|---|
| Revenue | €6.71b |
| Cost of Revenue | €5.19b |
| Gross Profit | €1.53b |
| Other Expenses | €945.40m |
| Earnings | €580.90m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.01 |
| Gross Margin | 22.74% |
| Net Profit Margin | 8.65% |
| Debt/Equity Ratio | 57.7% |
How did ESF perform over the long term?
See historical performance and comparison